[Matsuya R&D] Notice of Delisting | July 2026

Summary of Business Performance

This document reports that Matsuya R&D Corporation's Board of Directors, held on June 25, 2026, approved the share transfer request by Omron Healthcare Corporation, and accordingly decided on the delisting from the Tokyo Stock Exchange on the same day. The delisting is scheduled to occur on July 17, 2026, based on the resolution made on that day. Details are provided in the related materials disclosed on the same date.

Future Outlook and Impact on Shareholders

With the delisting, trading of shares and liquidity in the market will cease, which may result in decreased liquidity of assets and restrictions on sales for shareholders and investors. The company intends to continue to enhance corporate value and contribute to society, expressing gratitude to its shareholders. Details regarding capital policy and future business prospects are not included in this document.